MDT Valuation Metrics
MDT Stock Price Metrics
MDT Dividend Metrics
MDT Growth Rate Metrics
MDT Discounted Cash Flow Metrics
| Fair Value Price | $197.44 |
| Margin of Safety | 140.84% |
MDT Revenue Metrics
MDT PE Ratio Metrics
| PE Ratio | 21.98 |
| PE Ratio Avg TTM | 25.29 |
| PE Ratio Avg 3Y | 27.01 |
| Current VS TTM Avg | -13.10% |
| Current VS 3Y Avg | -18.63% |
| Current VS 5Y Avg | -23.62% |
MDT PS Ratio Metrics
| PS Ratio | 2.90 |
| PS Ratio Avg TTM | 3.42 |
| PS Ratio Avg 3Y | 3.42 |
| Current VS TTM Avg | -15.22% |
| Current VS 3Y Avg | -15.22% |
| Current VS 5Y Avg | -23.42% |
MDT PB Ratio Metrics
| PB Ratio | 2.16 |
| PB Ratio Avg TTM | 2.44 |
| PB Ratio Avg 3Y | 2.28 |
| Current VS TTM Avg | -11.44% |
| Current VS 3Y Avg | -5.25% |
| Current VS 5Y Avg | -10.26% |
MDT Price to Free Cash Flow Ratio Metrics
| PFCF Ratio | 19.46 |
| PFCF Ratio Avg TTM | 22.34 |
| PFCF Ratio Avg 3Y | 22.57 |
| Current VS TTM Avg | -12.90% |
| Current VS 3Y Avg | -13.78% |
| Current VS 5Y Avg | -18.04% |
MDT Debt to Equity Ratio Metrics
| Debt/Equity Ratio | 0.00 |
| Debt/Equity Ratio Avg TTM | 0.29 |
| Debt/Equity Ratio Avg 3Y | 0.39 |
| Current VS TTM Avg | -100.00% |
| Current VS 3Y Avg | -100.00% |
| Current VS 5Y Avg | -100.00% |
MDT PEG Ratio Metrics
| PEG Ratio | 6.73 |
| PEG Ratio Avg TTM | 6.73 |
| PEG Ratio Avg 3Y | 6.73 |
| Current VS TTM Avg | 0.00% |
| Current VS 3Y Avg | 0.00% |
| Current VS 5Y Avg | 0.00% |
MDT FCF Yield
| FCF Yield | 5.14% |
| FCF Yield Avg TTM | 4.51% |
| FCF Yield Avg 3Y | 4.48% |
| Current VS TTM Avg | +13.86% |
| Current VS 3Y Avg | +14.76% |
| Current VS 5Y Avg | +19.28% |
MDT Earnings Yield
| Earnings Yield | 4.55% |
| Earnings Yield Avg TTM | 3.97% |
| Earnings Yield Avg 3Y | 3.73% |
| Current VS TTM Avg | +14.47% |
| Current VS 3Y Avg | +22.05% |
| Current VS 5Y Avg | +26.17% |
MDT EV/EBIT Ratio Metrics
| Ev/Ebit Ratio | 20.91 |
| Ev/Ebit Ratio Avg TTM | 23.60 |
| Ev/Ebit Ratio Avg 3Y | 24.35 |
| Current VS TTM Avg | -11.42% |
| Current VS 3Y Avg | -14.11% |
| Current VS 5Y Avg | -21.56% |
MDT EV/EBITDA Ratio Metrics
| Ev/Ebitda Ratio | 14.17 |
| Ev/Ebitda Ratio Avg TTM | 15.65 |
| Ev/Ebitda Ratio Avg 3Y | 15.64 |
| Current VS TTM Avg | -9.43% |
| Current VS 3Y Avg | -9.42% |
| Current VS 5Y Avg | -16.42% |
MDT EV/Assets Ratio Metrics
| Ev/Assets Ratio | 1.45 |
| Ev/Assets Ratio Avg TTM | 1.59 |
| Ev/Assets Ratio Avg 3Y | 1.53 |
| Current VS TTM Avg | -8.84% |
| Current VS 3Y Avg | -5.01% |
| Current VS 5Y Avg | -9.23% |
MDT EV/Sales Ratio Metrics
| Ev/Sales Ratio | 3.73 |
| Ev/Sales Ratio Avg TTM | 4.21 |
| Ev/Sales Ratio Avg 3Y | 4.19 |
| Current VS TTM Avg | -11.32% |
| Current VS 3Y Avg | -10.97% |
| Current VS 5Y Avg | -17.73% |
MDT Current Ratio Metrics
| Current Ratio | 1.85 |
| Current Ratio Avg TTM | 1.94 |
| Current Ratio Avg 3Y | 2.03 |
| Current VS TTM Avg | -4.64% |
| Current VS 3Y Avg | -8.98% |
| Current VS 5Y Avg | -14.19% |
MDT Quick Ratio Metrics
| Quick Ratio | 1.42 |
| Quick Ratio Avg TTM | 1.48 |
| Quick Ratio Avg 3Y | 1.57 |
| Current VS TTM Avg | -4.38% |
| Current VS 3Y Avg | -9.41% |
| Current VS 5Y Avg | -15.58% |
MDT ROIC Metrics
| ROIC | 0.00% |
| ROIC Avg 3Y | 3.93% |
| ROIC Avg 5Y | 4.51% |
| Current VS 3Y Avg | -100.00% |
| Current VS 5Y Avg | -100.00% |
| Current VS 10Y Avg | -100.00% |
MDT Return on Assets Metrics
| ROA | 0.00 |
| ROA Avg TTM | 2.54 |
| ROA Avg 3Y | 3.33 |
| Current VS TTM Avg | -100.00% |
| Current VS 3Y Avg | -100.00% |
| Current VS 5Y Avg | -100.00% |
MDT Return on Equity Metrics
| ROE | 0.00 |
| ROE Avg TTM | 4.86 |
| ROE Avg 3Y | 6.08 |
| Current VS TTM Avg | -100.00% |
| Current VS 3Y Avg | -100.00% |
| Current VS 5Y Avg | -100.00% |
MDT Net Profit Margin Metrics
| Net Profit Margin | 13.20% |
| Net Profit Margin Avg TTM | 13.55% |
| Net Profit Margin Avg 3Y | 12.62% |
| Current VS TTM Avg | -2.58% |
| Current VS 3Y Avg | +4.58% |
| Current VS 5Y Avg | +1.07% |
Last Updated: Tuesday, June 9, 2026
About Medtronic plc
Medtronic plc is a leading global medical technology enterprise that invents, develops, manufactures, and distributes an extensive range of device-based medical therapies. These solutions serve healthcare systems, clinicians, physicians, and patients across the world. The company's operations are categorized into several key portfolios: Cardiovascular Portfolio: This segment focuses on cardiac health, providing technologies for heart rhythm management, including implantable pacemakers, defibrillators, and monitoring systems, alongside cardiac ablation tools and remote patient software. It also addresses structural heart issues with products like aortic and pulmonary valves, surgical repair devices, and endovascular stent grafts, in addition to offerings for percutaneous coronary interventions (e.g., angioplasty balloons). Medical Surgical Portfolio: Offering a broad spectrum of surgical instruments and therapies, this division includes staples, vessel sealing devices, wound closure products, and electrosurgical equipment. It also pioneers surgical artificial intelligence and robotic-assisted platforms, alongside solutions for hernia repair, gynecology, lung conditions, minimally invasive gastrointestinal and hepatologic diagnostics, patient monitoring, airway management, ventilation therapies, and renal disease. Neuroscience Portfolio: This division delivers specialized products for a diverse group of medical professionals, such as spinal surgeons, neurosurgeons, neurologists, pain management specialists, and ENT experts. Its offerings span energy surgical instruments, advanced image-guided and intra-operative imaging systems, robotic guidance for spine procedures, and therapies targeting the brain's vasculature. Diabetes Operating Unit: Dedicated to diabetes management, this unit provides innovative solutions like insulin pumps and their associated consumables, continuous glucose monitoring (CGM) systems, and smart insulin pen technologies. Established in 1949, Medtronic plc maintains its corporate headquarters in Dublin, Ireland.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Geoffrey Straub Martha